Comparator: Measles, Mumps, and Rubella Virus Vaccine Live

BIOLOGICAL2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

MeaslesMumpsRubellaVaricella

Phase 2

Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)

CompletedNCT00092404

Merck Sharp & Dohme LLCMeasles, Mumps, Rubella +1

Start: 2001-12-31End: 2005-06-30Updated: 2017-03-15

A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)

CompletedNCT00109278

Merck Sharp & Dohme LLCMeasles

Start: 2004-10-31End: 2005-05-31Updated: 2017-03-15